Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study

Authors

J. Blay
P. Schoffski
S. Bauer
A. Krarup-Hansen
C. Benson
D. R. D'Adamo
Y. Jia
R. G. Maki, Zucker School of Medicine at Hofstra/Northwell

Publication Date

2019

Journal Title

Br J Cancer

Volume Number

120

Issue Number

11

Pages

1026 - 1032

Document Type

Article

Status

Faculty

Facility

School of Medicine

Primary Department

Hematology/Medical Oncology

PMID

31065111

DOI

10.1038/s41416-019-0462-1